DE69434470D1 - Zellkernmatrixproteine - Google Patents

Zellkernmatrixproteine

Info

Publication number
DE69434470D1
DE69434470D1 DE69434470T DE69434470T DE69434470D1 DE 69434470 D1 DE69434470 D1 DE 69434470D1 DE 69434470 T DE69434470 T DE 69434470T DE 69434470 T DE69434470 T DE 69434470T DE 69434470 D1 DE69434470 D1 DE 69434470D1
Authority
DE
Germany
Prior art keywords
matrix proteins
nmps
nmp
nucleus matrix
nucleus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69434470T
Other languages
English (en)
Other versions
DE69434470T2 (de
Inventor
S Coffey
W Partin
H Getzenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
School of Medicine of Johns Hopkins University
Original Assignee
Johns Hopkins University
School of Medicine of Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University, School of Medicine of Johns Hopkins University filed Critical Johns Hopkins University
Publication of DE69434470D1 publication Critical patent/DE69434470D1/de
Application granted granted Critical
Publication of DE69434470T2 publication Critical patent/DE69434470T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69434470T 1993-02-09 1994-02-08 Zellkernmatrixproteine Expired - Fee Related DE69434470T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1562493A 1993-02-09 1993-02-09
US15624 1993-02-09
PCT/US1994/001360 WO1994018222A1 (en) 1993-02-09 1994-02-08 Nuclear matrix proteins

Publications (2)

Publication Number Publication Date
DE69434470D1 true DE69434470D1 (de) 2005-09-29
DE69434470T2 DE69434470T2 (de) 2006-06-22

Family

ID=21772525

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69434470T Expired - Fee Related DE69434470T2 (de) 1993-02-09 1994-02-08 Zellkernmatrixproteine

Country Status (7)

Country Link
US (7) US5824490A (de)
EP (1) EP0684955B1 (de)
JP (1) JPH08508396A (de)
AT (1) ATE302789T1 (de)
CA (1) CA2155645A1 (de)
DE (1) DE69434470T2 (de)
WO (1) WO1994018222A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0684955B1 (de) * 1993-02-09 2005-08-24 The Johns Hopkins University School Of Medicine Zellkernmatrixproteine
US5977316A (en) * 1995-01-17 1999-11-02 The Board Of Trustees Of The University Of Kentucky Monoclonal antibody 1A7 and related polypeptides
JPH10512158A (ja) * 1995-11-03 1998-11-24 ゲッツェンバーグ，ロバート・エイチ 膀胱の核マトリックスタンパク質ならびに細胞増殖性疾患の検出及び治療におけるその使用
US6280956B1 (en) 1995-11-03 2001-08-28 University Of Pittsburgh Antibodies to bladder cancer nuclear matrix proteins and their use
US5914238A (en) * 1996-06-05 1999-06-22 Matritech, Inc. Materials and methods for detection of breast cancer
US6232443B1 (en) * 1997-04-08 2001-05-15 University Of Pittsburgh Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
GB9721901D0 (en) * 1997-10-16 1997-12-17 Univ Manchester Particles
JPH11232291A (ja) * 1998-02-16 1999-08-27 Seibutsu Bunshi Kogaku Kenkyusho:Kk 蛋白質立体構造データベース検索方法
US6232287B1 (en) * 1998-03-13 2001-05-15 The Burnham Institute Molecules that home to various selected organs or tissues
EP1104462B1 (de) * 1998-08-10 2007-01-03 Agensys, Inc. Bpc-1: ein ausgeschiedenes gehirnspezifisches protein das von prostata- und blasen-krebszellen exprimiert und ausgeschieden wird
WO2000023624A1 (en) * 1998-10-22 2000-04-27 Duke University Methods of screening for risk of proliferative disease and methods for the treatment of proliferative disease
US6617432B1 (en) * 1999-10-15 2003-09-09 University Of Pittsburgh Nuclear matrix proteins polynucleotide sequences encoding them and their use
US20030228640A1 (en) * 1999-10-15 2003-12-11 University Of Pittsburgh Nuclear matrix proteins, polynucleotide sequences encoding them, and their use
US20040018973A1 (en) * 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
AU2003247576A1 (en) * 2002-06-18 2003-12-31 Archemix Corp. Aptamer-toxin molecules and methods for using same
US20040249130A1 (en) * 2002-06-18 2004-12-09 Martin Stanton Aptamer-toxin molecules and methods for using same
US8853376B2 (en) 2002-11-21 2014-10-07 Archemix Llc Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
US20050118102A1 (en) * 2003-04-28 2005-06-02 Intematix Corporation Spin resonance heating and/or imaging in medical applications
WO2006116021A2 (en) * 2005-04-22 2006-11-02 Intematix Corporation Mri technique based on electron spin resonance and endohedral contrast agent
DE102007037008B4 (de) * 2007-08-06 2015-09-10 Siemens Aktiengesellschaft Diagnosesubstanz zur Anwendung in einem Verfahren zur Bestimmung der Aggressivität eines Prostatatumors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882268A (en) * 1985-12-24 1989-11-21 Massachusetts Institute Of Technology Method for determining tissue of origin and degree of malignancy of tumor cells
JPH05146294A (ja) * 1991-11-27 1993-06-15 Sankyo Co Ltd 癌関連蛋白質
AU681855B2 (en) * 1992-06-22 1997-09-11 Matritech, Inc. Novel malignant cell type markers of the interior nuclear matrix
EP0684955B1 (de) * 1993-02-09 2005-08-24 The Johns Hopkins University School Of Medicine Zellkernmatrixproteine

Also Published As

Publication number Publication date
US5824490A (en) 1998-10-20
WO1994018222A1 (en) 1994-08-18
ATE302789T1 (de) 2005-09-15
CA2155645A1 (en) 1994-08-18
US5849509A (en) 1998-12-15
US20020168695A1 (en) 2002-11-14
EP0684955A1 (de) 1995-12-06
US6030793A (en) 2000-02-29
EP0684955B1 (de) 2005-08-24
US20030143621A1 (en) 2003-07-31
US5874539A (en) 1999-02-23
DE69434470T2 (de) 2006-06-22
JPH08508396A (ja) 1996-09-10
US20060172352A1 (en) 2006-08-03
EP0684955A4 (de) 1997-07-30

Similar Documents

Publication Publication Date Title
DE69434470D1 (de) Zellkernmatrixproteine
PT939767E (pt) Factor viii porcino e seus hibridos
ATE173505T1 (de) Nukleotidsequenzen kodierend für ein humanes protein mit angiogenetisch-regulatorischen eigenschaften
ATE145940T1 (de) Dns-sequenzen, die polypeptiden mit beta-1,3- glukanase-aktivität codieren
DE69419678D1 (de) Entwurfsverfahren für luftreifen
NO892033D0 (no) Fibronectinbindende protein.
ES2218872T3 (es) Polipeptido 10 de tipo citoquina de mamifero.
DE68914664D1 (de) Gereinigte ubiquitin-hydrolase, diese kodierende dns-sequenzen und ihre verwendung zur gewinnung von polypeptiden.
MX9705025A (es) Proteinas de matriz nuclear de vejiga y su uso para detectar y tratar trastornos proliferativos celulares.
MX9602977A (es) Proteinas que reparan la mala union de adn humano.
DE68902784D1 (de) Auswechselbarer quenchgas-injektionsring.
ES545725A0 (es) Procedimiento para preparar peptidos de interferon
ATE235550T1 (de) Ikaros: ein regulatorisches gen bei der t-zell differenzierung
DE69426121T2 (de) Gen grb3-3, variante und ihre verwendungen
DE68908839D1 (de) Anordnung zur Fehlerstrombegrenzung.
ATE175237T1 (de) Polypeptide beteiligt an der kobalamin- und/oder kobamid-biosynthese, für diese kodierende dns- sequencen, und ihre herstellung und vewendung.
MX9702863A (es) Proteinas asociadas con el hipocampo, secuencias de adn que codifican para las mismas y usos de las mismas.
ATE215123T1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
WO2001029218A3 (en) Nuclear matrix proteins, polynucleotide sequences encoding them, and their use
DK1129191T3 (da) Fremgangsmåder til diagnosticering eller behandling af neurologiske sygdomme
DK0941341T3 (da) Nukleotidsekvens, der koder for en flavinmonooxygenase, det tilsvarende protein og deres anvendelser inden for diagnostik og terapi
UA27771C2 (uk) Електролітична комірка (варіанти) та спосіб мічення протеїнів, пептидів і інших органічних молекул
DE69422588D1 (de) Steueranordnung für einen elektrischen Apparat
ES2165358T3 (es) Utilizaciones de la proteinquinasa de neurofilamento/tau pk40.
NO880099D0 (no) Beskyttelseskrage for karbonanoder.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee